Mark Papania

2.0k total citations
40 papers, 1.2k citations indexed

About

Mark Papania is a scholar working on Epidemiology, Health and Immunology. According to data from OpenAlex, Mark Papania has authored 40 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Epidemiology, 22 papers in Health and 14 papers in Immunology. Recurrent topics in Mark Papania's work include Virology and Viral Diseases (30 papers), Vaccine Coverage and Hesitancy (22 papers) and Immune responses and vaccinations (11 papers). Mark Papania is often cited by papers focused on Virology and Viral Diseases (30 papers), Vaccine Coverage and Hesitancy (22 papers) and Immune responses and vaccinations (11 papers). Mark Papania collaborates with scholars based in United States, Switzerland and Australia. Mark Papania's co-authors include Walter A. Orenstein, Paul A. Rota, William J. Bellini, Susan B. Redd, Jennifer S. Rota, Peter M. Strebel, Susan E. Reef, Jane F. Seward, Alan R. Hinman and Stephen L. Cochi and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and PEDIATRICS.

In The Last Decade

Mark Papania

40 papers receiving 1.1k citations

Peers

Countries citing papers authored by Mark Papania

Since Specialization

Citations

This map shows the geographic impact of Mark Papania's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Papania with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Papania more than expected).

Fields of papers citing papers by Mark Papania

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Papania. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Papania. The network helps show where Mark Papania may publish in the future.

Co-authorship network of co-authors of Mark Papania

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Papania. A scholar is included among the top collaborators of Mark Papania based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Papania. Mark Papania is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Title	Journal	Authors	Indexed citations
1	Estimates of Potential Demand for Measles and Rubella Microarray Patches	Vaccines	Leah S. Fischer, Bishwa B. Adhikari et al.	1
2	Use of Measles and Rubella Rapid Diagnostic Tests to Improve Case Detection and Targeting of Vaccinations	Vaccines	Lee M. Hampton, Paul A. Rota et al.	2
3	Estimating the future global dose demand for measles–rubella microarray patches	Frontiers in Public Health	Stefano Malvolti, Carsten Mantel et al.	9
4	Population-Level Risk Factors Related to Measles Case Fatality: A Conceptual Framework Based on Expert Consultation and Literature Review	Vaccines	Alyssa N. Sbarra, Mark Jit et al.	2
5	Lessons learnt from the applying the Centers for Disease Control and Prevention (CDC) evaluation framework to the measles incident management system response, USA, 2020–2021	BMJ Global Health	Gavin B. Grant, Rania A. Tohme et al.	2
6	Measles susceptibility in maternal-infant dyads—Bamako, Mali	Vaccine	Meredith G. Dixon, Milagritos D. Tapia et al.	6
7	Intranasal powder live attenuated influenza vaccine is thermostable, immunogenic, and protective against homologous challenge in ferrets	npj Vaccines	Jasmina M. Luczo, Tatiana Bousse et al.	12
8	Evaluation of a temperature-restricted, mucosal tuberculosis vaccine in guinea pigs	Tuberculosis	Rebecca L. Pavlicek, Simon O. Owino et al.	5
9	Intranasal Deposition of Accuspray™ Aerosol in Anatomically Correct Models of 2-, 5-, and 12-Year-Old Children	Journal of Aerosol Medicine and Pulmonary Drug Delivery	Beth L. Laube, S. James Zinreich et al.	17
10	Clinical performance and safety of adapters for intradermal delivery with conventional and autodisable syringes	Vaccine	Courtney Jarrahian, Eugene Saxon et al.	6
11	Effect of jet injection on infectivity of measles, mumps, and rubella vaccine in a bench model	Vaccine	Melissa M. Coughlin, Marcus L. Collins et al.	3
12	Nebulized live-attenuated influenza vaccine provides protection in ferrets at a reduced dose	Vaccine	Mark Papania, Darin A. Knaus et al.	17
13	Aerosol vaccination induces robust protective immunity to homologous and heterologous influenza infection in mice	Vaccine	Paula Brooks, Scott K. Johnson et al.	14
14	Heterologous Prime–Boost Strategy to Immunize Very Young Infants against Measles: Pre-clinical Studies in Rhesus Macaques	Clinical Pharmacology & Therapeutics	Marcela F. Pasetti, Aldo Arturo Reséndiz‐Albor et al.	27
15	Aerosol measles vaccination in macaques: Preclinical studies of immune responses and safety	Vaccine	Rik L. de Swart, Thijs Kuiken et al.	29
16	Congenital rubella syndrome burden in Morocco: a rapid retrospective assessment	The Lancet	A. Berraho, Susan E. Reef et al.	29
17	Measles outbreak in the Republic of the Marshall Islands, 2003	International Journal of Epidemiology	Terri B. Hyde, Gustavo H. Dayan et al.	29
18	Measles surveillance: the importance of finding the tip of the iceberg	The Lancet	Mark Papania, Peter M. Strebel	10
19	Evolution of Measles Elimination Strategies in the United States	The Journal of Infectious Diseases	Walter A. Orenstein, Alan R. Hinman et al.	55
20	Measles eradication: is it in our future?	American Journal of Public Health	Walter A. Orenstein, Peter M. Strebel et al.	92

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact